These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. High prevalence of ATTR amyloidosis in endomyocardial biopsy-proven cardiac amyloidosis patients. Nakagawa M; Sekijima Y; Tojo K; Ikeda S Amyloid; 2013 Jun; 20(2):138-40. PubMed ID: 23638696 [TBL] [Abstract][Full Text] [Related]
29. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment. Siddiqi OK; Ruberg FL Trends Cardiovasc Med; 2018 Jan; 28(1):10-21. PubMed ID: 28739313 [TBL] [Abstract][Full Text] [Related]
30. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. Sperry BW; Reyes BA; Ikram A; Donnelly JP; Phelan D; Jaber WA; Shapiro D; Evans PJ; Maschke S; Kilpatrick SE; Tan CD; Rodriguez ER; Monteiro C; Tang WHW; Kelly JW; Seitz WH; Hanna M J Am Coll Cardiol; 2018 Oct; 72(17):2040-2050. PubMed ID: 30336828 [TBL] [Abstract][Full Text] [Related]
31. Modulation of the Mechanisms Driving Transthyretin Amyloidosis. Bezerra F; Saraiva MJ; Almeida MR Front Mol Neurosci; 2020; 13():592644. PubMed ID: 33362465 [TBL] [Abstract][Full Text] [Related]
32. Allele specific expression of the transthyretin gene in swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles. Norgren N; Hellman U; Ericzon BG; Olsson M; Suhr OB PLoS One; 2012; 7(11):e49981. PubMed ID: 23185504 [TBL] [Abstract][Full Text] [Related]
33. Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosis. Gustafsson S; Ihse E; Henein MY; Westermark P; Lindqvist P; Suhr OB Transplantation; 2012 May; 93(10):1017-23. PubMed ID: 22395298 [TBL] [Abstract][Full Text] [Related]
34. Amyloid in endomyocardial biopsies. Kieninger B; Eriksson M; Kandolf R; Schnabel PA; Schönland S; Kristen AV; Hegenbart U; Lohse P; Röcken C Virchows Arch; 2010 May; 456(5):523-32. PubMed ID: 20376481 [TBL] [Abstract][Full Text] [Related]
35. Liver transplantation in transthyretin amyloidosis: issues and challenges. Carvalho A; Rocha A; Lobato L Liver Transpl; 2015 Mar; 21(3):282-92. PubMed ID: 25482846 [TBL] [Abstract][Full Text] [Related]
36. Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience. Rowczenio D; Quarta CC; Fontana M; Whelan CJ; Martinez-Naharro A; Trojer H; Baginska A; Ferguson SM; Gilbertson J; Rezk T; Sachchithanantham S; Mahmood S; Manwani R; Sharpley F; Wechalekar AD; Hawkins PN; Gillmore JD; Lachmann HJ Hum Mutat; 2019 Jan; 40(1):90-96. PubMed ID: 30328212 [TBL] [Abstract][Full Text] [Related]
37. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. Ihse E; Suhr OB; Hellman U; Westermark P J Mol Med (Berl); 2011 Feb; 89(2):171-80. PubMed ID: 21107516 [TBL] [Abstract][Full Text] [Related]
38. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know]. Arbustini E; Gavazzi A; Merlini G Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807 [TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299 [TBL] [Abstract][Full Text] [Related]